Patents by Inventor Sabine WIRTZ

Sabine WIRTZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant classical swine fever virus (CSFV) comprising substitution in the TAV epitope of the E2 protein
    Patent number: 9993544
    Abstract: The present invention relates i.a. to a CSFV (classical swine fever virus) comprising a substitution of proline to lysine at amino acid position 44 of the E2 protein and a substitution of threonine to aspartic acid at amino acid position 45 of the E2 protein. Further, the present invention provides an immunogenic composition comprising the CSFV of the present invention and the use of the immunogenic composition for reducing the incidence of or severity in an animal of one or more clinical signs associated with CSF. Moreover, the present invention provides a method of differentiating animals infected with CSFV from animals vaccinated with the immunogenic composition of the present invention.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: June 12, 2018
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Gregor Meyers, Sabine Wirtz
  • RECOMBINANT CLASSICAL SWINE FEVER VIRUS (CSFV) COMPRISING SUBSTITUTION IN THE TAV EPITOPE OF THE E2 PROTEIN
    Publication number: 20170119870
    Abstract: The present invention relates i.a. to a CSFV (classical swine fever virus) comprising a substitution of proline to lysine at amino acid position 44 of the E2 protein and a substitution of threonine to aspartic acid at amino acid position 45 of the E2 protein. Further, the present invention provides an immunogenic composition comprising the CSFV of the present invention and the use of the immunogenic composition for reducing the incidence of or severity in an animal of one or more clinical signs associated with CSF. Moreover, the present invention provides a method of differentiating animals infected with CSFV from animals vaccinated with the immunogenic composition of the present invention.
    Type: Application
    Filed: May 22, 2015
    Publication date: May 4, 2017
    Inventors: Gregor MEYERS, Sabine WIRTZ